Mechanisms of atrial fibrillation termination by pure sodium channel blockade in an ionically-realistic mathematical model
Mechanisms of atrial fibrillation termination by pure sodium channel blockade in an ionically-realistic mathematical model
复制标题
DOI:
10.1161/01.res.0000160709.49633.2b
复制
发表时间:
2005-03-18
影响因子:
20.1
通讯作者:
Jalife, J
中科院分区:
文献类型:
--
作者:
Kneller, J;Kalifa, J;Jalife, J
The mechanisms by which Na+-channel blocking antiarrhythmic drugs terminate atrial fibrillation (AF) remain unclear. Classical "leading-circle" theory suggests that Na+-channel blockade should, if anything, promote re-entry. We used an ionically-based mathematical model of vagotonic AF to evaluate the effects of applying pure Na+-current (I-Na) inhibition during sustained arrhythmia. Under control conditions, AF was maintained by 1 or 2 dominant spiral waves, with fibrillatory propagation at critical levels of action potential duration (APD) dispersion. I-Na inhibition terminated AF increasingly with increasing block, terminating all AF at 65% block. During 1:1 conduction, I-Na inhibition reduced APD (by 13% at 4 Hz and 60% block), conduction velocity (by 37%), and re-entry wavelength (by 24%). During AF, I-Na inhibition increased the size of primary rotors and reduced re-entry rate (eg, dominant frequency decreased by 33% at 60% I-Na inhibition) while decreasing generation of secondary wavelets by wavebreak. Three mechanisms contributed to I-Na block-induced AF termination in the model: (1) enlargement of the center of rotation beyond the capacity of the computational substrate; (2) decreased anchoring to functional obstacles, increasing meander and extinction at boundaries; and (3) reduction in the number of secondary wavelets that could provide new primary rotors. Optical mapping in isolated sheep hearts confirmed that tetrodotoxin dose-dependently terminates AF while producing effects qualitatively like those of I-Na inhibition in the mathematical model. We conclude that pure I-Na inhibition terminates AF, producing activation changes consistent with previous clinical and experimental observations. These results provide insights into previously enigmatic mechanisms of class I antiarrhythmic drug-induced AF termination.